Spectrum Pharmaceuticals, Inc. (SPPI)
NASDAQ: SPPI · IEX Real-Time Price · USD
1.36
+0.15 (12.40%)
At close: Aug 12, 2022 4:00 PM
1.42
+0.06 (4.41%)
After-hours:
Aug 12, 2022 7:59 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
|
0 | 0 | 0 | 0 | 0 | 146.44 | 162.56 | 186.83 | 155.85 | 267.71 | Upgrade
|
Revenue Growth (YoY)
|
- | - | - | - | - | -9.91% | -12.99% | 19.88% | -41.78% | 38.73% | Upgrade
|
Cost of Revenue
|
0 | 0 | 0 | 0 | 0 | 35.84 | 27.69 | 27.04 | 28.58 | 46.63 | Upgrade
|
Gross Profit
|
0 | 0 | 0 | 0 | 0 | 110.6 | 134.87 | 159.79 | 127.27 | 221.07 | Upgrade
|
Selling, General & Admin
|
60.41 | 60.36 | 61.37 | 62.69 | 64.76 | 88.42 | 88.06 | 97.41 | 99.32 | 89.92 | Upgrade
|
Research & Development
|
87.3 | 109.38 | 79.33 | 75.16 | 51.53 | 59.12 | 51.07 | 69.66 | 46.67 | 41.56 | Upgrade
|
Other Operating Expenses
|
0 | 0 | 0 | 0 | 0 | 25.95 | 38.32 | 24.29 | 20.07 | 8.82 | Upgrade
|
Operating Expenses
|
147.7 | 169.73 | 140.7 | 137.85 | 116.28 | 173.49 | 177.46 | 191.36 | 166.06 | 140.3 | Upgrade
|
Operating Income
|
-147.7 | -169.73 | -140.7 | -137.85 | -116.28 | -62.89 | -42.59 | -31.57 | -38.79 | 80.77 | Upgrade
|
Interest Expense / Income
|
0 | 0 | 0 | 0 | 0 | 9.44 | 9.07 | 8.58 | 2.19 | 0.49 | Upgrade
|
Other Expense / Income
|
10.92 | -8.81 | -18.8 | -15.21 | -2.15 | -0.24 | 0.57 | 3.38 | -4.34 | 0.36 | Upgrade
|
Pretax Income
|
-158.62 | -160.93 | -121.9 | -122.64 | -114.13 | -72.08 | -52.24 | -43.53 | -36.64 | 79.93 | Upgrade
|
Income Tax
|
0 | -0.06 | -9.21 | -1.9 | -21.94 | -2.31 | 0.41 | 2.19 | 25.5 | -14.27 | Upgrade
|
Net Income
|
-158.63 | -160.87 | -112.69 | -120.74 | -92.19 | -69.77 | -52.64 | -45.72 | -62.13 | 94.2 | Upgrade
|
Net Income Common
|
-158.63 | -160.87 | -112.69 | -120.74 | -92.19 | -69.77 | -52.64 | -45.72 | -62.13 | 94.2 | Upgrade
|
Net Income Growth
|
- | - | - | - | - | - | - | - | - | 88.66% | Upgrade
|
Shares Outstanding (Basic)
|
155 | 124 | 111 | 103 | 85 | 73 | 65 | 65 | 61 | 59 | Upgrade
|
Shares Outstanding (Diluted)
|
155 | 124 | 111 | 103 | 85 | 73 | 65 | 65 | 61 | 65 | Upgrade
|
Shares Change
|
24.50% | 12.48% | 7.05% | 21.37% | 16.88% | 12.24% | 0.27% | 6.55% | -6.05% | 11.52% | Upgrade
|
EPS (Basic)
|
-1.02 | -1.29 | -1.02 | -1.17 | -1.08 | -0.96 | -0.81 | -0.71 | -1.02 | 1.61 | Upgrade
|
EPS (Diluted)
|
-1.02 | -1.29 | -1.02 | -1.17 | -1.08 | -0.96 | -0.81 | -0.71 | -1.02 | 1.46 | Upgrade
|
EPS Growth
|
- | - | - | - | - | - | - | - | - | 69.77% | Upgrade
|
Free Cash Flow Per Share
|
-0.77 | -1.02 | -1.30 | -0.60 | -0.46 | -0.56 | 0.10 | -0.46 | -0.04 | 1.22 | Upgrade
|
Dividend Per Share
|
- | - | - | - | - | - | - | - | - | 0.150 | Upgrade
|
Gross Margin
|
- | - | - | - | - | 75.50% | 83.00% | 85.50% | 81.70% | 82.60% | Upgrade
|
Operating Margin
|
- | - | - | - | - | -42.90% | -26.20% | -16.90% | -24.90% | 30.20% | Upgrade
|
Profit Margin
|
- | - | - | - | - | -47.60% | -32.40% | -24.50% | -39.90% | 35.20% | Upgrade
|
Free Cash Flow Margin
|
- | - | - | - | - | -27.70% | 4.00% | -15.80% | -1.40% | 26.80% | Upgrade
|
Effective Tax Rate
|
-0.00% | 0.04% | 7.55% | 1.55% | 19.22% | 3.21% | -0.78% | -5.02% | -69.60% | -17.85% | Upgrade
|
EBITDA
|
-156.71 | -159.13 | -118.56 | -94.23 | -86.16 | -36.16 | -11.29 | -9.6 | -12.35 | 92.66 | Upgrade
|
EBITDA Margin
|
- | - | - | - | - | -24.70% | -6.90% | -5.10% | -7.90% | 34.60% | Upgrade
|
Depreciation & Amortization
|
1.91 | 1.8 | 3.34 | 28.41 | 27.97 | 26.49 | 31.87 | 25.35 | 22.1 | 12.24 | Upgrade
|
EBIT
|
-158.62 | -160.93 | -121.9 | -122.64 | -114.13 | -62.65 | -43.16 | -34.95 | -34.44 | 80.42 | Upgrade
|
EBIT Margin
|
- | - | - | - | - | -42.80% | -26.60% | -18.70% | -22.10% | 30.00% | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).